Precipio Inc./$PRPO
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Precipio Inc.
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.
- Ticker
- $PRPO
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 66
- Headquarters
- New Haven, United States
- Website
- www.precipiodx.com
Precipio Inc. Metrics
BasicAdvanced
$44M
-
-$0.64
-
-
Price and volume
Market cap
$44M
52-week high
$33.63
52-week low
$17.79
Average daily volume
34K
Financial strength
Current ratio
1.768
Quick ratio
1.411
Long term debt to equity
0.193
Total debt to equity
0.248
Interest coverage (TTM)
-29.66%
Profitability
EBITDA (TTM)
-0.056
Gross margin (TTM)
44.56%
Net profit margin (TTM)
-4.12%
Operating margin (TTM)
-5.34%
Revenue per employee (TTM)
$420,000
Management effectiveness
Return on assets (TTM)
-4.32%
Return on equity (TTM)
-8.00%
Valuation
Price to revenue (TTM)
1.591
Price to book
2.99
Price to tangible book (TTM)
9.54
Price to free cash flow (TTM)
31.852
Free cash flow yield (TTM)
3.14%
Free cash flow per share (TTM)
0.779
Growth
Revenue change (TTM)
21.76%
Earnings per share change (TTM)
-21.29%
3-year revenue growth (CAGR)
27.93%
3-year earnings per share growth (CAGR)
-55.68%
Precipio Inc. Financial Performance
Revenues and expenses
Precipio Inc. Earnings Performance
Company profitability
Upcoming events
No upcoming events
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.